Title: Journal of the National Cancer Center: Advancing Cancer Research and Health Policies
Introduction: The Journal of the National Cancer Center (JNCC) is a distinguished, peer-reviewed, and fully open-access journal launched in March 2021. With a focus on promoting high-quality articles in all areas of cancer research, the journal aims to address fundamental questions of cancer biology and epidemiology, while advancing approaches for cancer prevention, detection, diagnosis, and treatment. As an esteemed platform, JNCC communicates cutting-edge advances in cancer research and related health policies, encompassing a wide range of article types.
Scope and Aims: JNCC endeavors to publish original research articles, news stories, systematic and focused reviews, commentaries, brief communications, correspondences, and editorials, encompassing diverse aspects of cancer research. The journal is committed to facilitating a timely and efficient review process, ensuring significant scientific findings are disseminated promptly. Emphasizing the importance of clinical research, JNCC particularly encourages submissions of randomized controlled clinical trials, for which expedited review will be provided.
Supervised by the National Health Commission of China and sponsored by the National Cancer Center (NCC), JNCC operates under the auspices of China’s national authority for cancer prevention and control. NCC plays a pivotal role in developing national cancer prevention strategies, overseeing the national cancer registration network, establishing clinical guidelines for diagnosis and treatment, promoting clinical trials for new cancer therapies, implementing cancer screening and early detection programs, and conducting scientific research on cancer prevention and control.
Promoting Collaboration and International Cooperation: JNCC actively fosters academic exchanges and international cooperation with esteemed organizations and institutes worldwide, including the International Agency for Research on Cancer (IARC), U.S. National Cancer Institute (NCI), Asian National Cancer Center Alliance (ANCCA), Cancer Research UK (CRUK), and prestigious universities. Such collaborations ensure a global perspective in cancer research and contribute to the dissemination of cutting-edge findings.
Conclusion: As a pioneering open-access journal supervised by the National Health Commission of China and sponsored by the National Cancer Center, JNCC plays a crucial role in advancing cancer research and related health policies. By providing a prominent platform for high-quality research, the journal facilitates the exchange of knowledge among cancer researchers and clinicians worldwide. With a rigorous yet rapid review process, JNCC promptly disseminates significant scientific insights, contributing to improved cancer prevention, diagnosis, and treatment strategies, and ultimately, better patient outcomes.
Volume 3, Issue 1: Pages 1-92 (March 2023)
Volume 3, Issue 2: Pages 93-158 (June 2023)
Volume 3, Issue 3: Pages 159-250 (September 2023)
Volume 3, Issue 4: Pages 251-310 (December 2023)
Volume 4, Issue 1: Pages 1-92 (March 2024)
Volume 4, Issue 2: Pages 93-188 (June 2024)
Volume 4, Issue 3: Pages 189-288 (September 2024)